Literature DB >> 18648382

Neuroprotection in diet-induced ketotic rat brain after focal ischemia.

Michelle A Puchowicz1, Jennifer L Zechel, Jose Valerio, Douglas S Emancipator, Kui Xu, Svetlana Pundik, Joseph C LaManna, W David Lust.   

Abstract

Neuroprotective properties of ketosis may be related to the upregulation of hypoxia inducible factor (HIF)-1alpha, a primary constituent associated with hypoxic angiogenesis and a regulator of neuroprotective responses. The rationale that the utilization of ketones by the brain results in elevation of intracellular succinate, a known inhibitor of prolyl hydroxylase (the enzyme responsible for the degradation of HIF-1alpha) was deemed as a potential mechanism of ketosis on the upregulation of HIF-1alpha. The neuroprotective effect of diet-induced ketosis (3 weeks of feeding a ketogenic diet), as pretreatment, on infarct volume, after reversible middle cerebral artery occlusion (MCAO), and the upregulation of HIF-1alpha were investigated. The effect of beta-hydroxybutyrate (BHB), as a pretreatment, via intraventricular infusion (4 days of infusion before stroke) was also investigated following MCAO. Levels of HIF-1alpha and Bcl-2 (anti-apoptotic protein) proteins and succinate content were measured. A 55% or 70% reduction in infarct volume was observed with BHB infusion or diet-induced ketosis, respectively. The levels of HIF-1alpha and Bcl-2 proteins increased threefold with diet-induced ketosis; BHB infusions also resulted in increases in these proteins. As hypothesized, succinate content increased by 55% with diet-induced ketosis and fourfold with BHB infusion. In conclusion, the biochemical link between ketosis and the stabilization of HIF-1alpha is through the elevation of succinate, and both HIF-1alpha stabilization and Bcl-2 upregulation play a role in ketone-induced neuroprotection in the brain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18648382      PMCID: PMC3621146          DOI: 10.1038/jcbfm.2008.79

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  42 in total

Review 1.  Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential.

Authors:  Mark Slevin; Pat Kumar; John Gaffney; Shant Kumar; Jerzy Krupinski
Journal:  Clin Sci (Lond)       Date:  2006-09       Impact factor: 6.124

2.  D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease.

Authors:  Y Kashiwaya; T Takeshima; N Mori; K Nakashima; K Clarke; R L Veech
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  Expression of hypoxia-inducible factor-1alpha in the brain of rats during chronic hypoxia.

Authors:  J C Chávez; F Agani; P Pichiule; J C LaManna
Journal:  J Appl Physiol (1985)       Date:  2000-11

Review 4.  Ketone body synthesis in the brain: possible neuroprotective effects.

Authors:  Manuel Guzmán; Cristina Blázquez
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2004-03       Impact factor: 4.006

Review 5.  The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism.

Authors:  Richard L Veech
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2004-03       Impact factor: 4.006

6.  Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study.

Authors:  Mark W Parsons; P Alan Barber; Patricia M Desmond; Tracey A Baird; David G Darby; Graham Byrnes; Brian M Tress; Stephen M Davis
Journal:  Ann Neurol       Date:  2002-07       Impact factor: 10.422

7.  Ischemic cell death: dynamics of delayed secondary energy failure during reperfusion following focal ischemia.

Authors:  W David Lust; Christopher Taylor; Svetlana Pundik; Warren R Selman; Robert A Ratcheson
Journal:  Metab Brain Dis       Date:  2002-06       Impact factor: 3.584

8.  Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia.

Authors:  Motohisa Suzuki; Mayumi Suzuki; Yukika Kitamura; Saori Mori; Kazunori Sato; Sekiko Dohi; Takashi Sato; Akihiro Matsuura; Atsushi Hiraide
Journal:  Jpn J Pharmacol       Date:  2002-05

9.  Assessing the reversibility of the anaplerotic reactions of the propionyl-CoA pathway in heart and liver.

Authors:  Aneta E Reszko; Takhar Kasumov; Bradley A Pierce; France David; Charles L Hoppel; William C Stanley; Christine Des Rosiers; Henri Brunengraber
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

10.  Angiopoietin-2 and rat brain capillary remodeling during adaptation and deadaptation to prolonged mild hypoxia.

Authors:  Paola Pichiule; Joseph C LaManna
Journal:  J Appl Physiol (1985)       Date:  2002-09
View more
  64 in total

1.  Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke.

Authors:  Hwa Kyoung Shin; Fumiaki Oka; Ji Hyun Kim; Dmitriy Atochin; Paul L Huang; Cenk Ayata
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity.

Authors:  Xinxin Yang; Baohua Cheng
Journal:  J Mol Neurosci       Date:  2010-03-24       Impact factor: 3.444

3.  Protection of hypoglycemia-induced neuronal death by β-hydroxybutyrate involves the preservation of energy levels and decreased production of reactive oxygen species.

Authors:  Alberto Julio-Amilpas; Teresa Montiel; Eva Soto-Tinoco; Cristian Gerónimo-Olvera; Lourdes Massieu
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-04       Impact factor: 6.200

Review 4.  Purines and neuronal excitability: links to the ketogenic diet.

Authors:  S A Masino; M Kawamura; D N Ruskin; J D Geiger; D Boison
Journal:  Epilepsy Res       Date:  2011-08-30       Impact factor: 3.045

5.  Ketogenic diet compromises vertebral microstructure and biomechanical characteristics in mice.

Authors:  Xiuhua Wu; Jianyang Ding; Xiaolin Xu; Xiaomeng Wang; Junhao Liu; Jie Jiang; Qi Liu; Ganggang Kong; Zucheng Huang; Zhou Yang; Qingan Zhu
Journal:  J Bone Miner Metab       Date:  2019-04-09       Impact factor: 2.626

6.  A ketone ester diet increases brain malonyl-CoA and Uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar Rat.

Authors:  Yoshihiro Kashiwaya; Robert Pawlosky; William Markis; M Todd King; Christian Bergman; Shireesh Srivastava; Andrew Murray; Kieran Clarke; Richard L Veech
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

7.  Decreased carbon shunting from glucose toward oxidative metabolism in diet-induced ketotic rat brain.

Authors:  Yifan Zhang; Shenghui Zhang; Isaac Marin-Valencia; Michelle A Puchowicz
Journal:  J Neurochem       Date:  2014-11-10       Impact factor: 5.372

Review 8.  Adenosine and Ketogenic Treatments.

Authors:  David N Ruskin; Masahito Kawamura; Susan A Masino
Journal:  J Caffeine Adenosine Res       Date:  2020-09-16

9.  Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial.

Authors:  Samuel T Henderson; Janet L Vogel; Linda J Barr; Fiona Garvin; Julie J Jones; Lauren C Costantini
Journal:  Nutr Metab (Lond)       Date:  2009-08-10       Impact factor: 4.169

10.  Hyperlipidemia disrupts cerebrovascular reflexes and worsens ischemic perfusion defect.

Authors:  Cenk Ayata; Hwa Kyoung Shin; Ergin Dileköz; Dmitriy N Atochin; Satoshi Kashiwagi; Katharina Eikermann-Haerter; Paul L Huang
Journal:  J Cereb Blood Flow Metab       Date:  2013-03-13       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.